COMMUNIQUÉS West-GlobeNewswire

Novartis real-world evidence confirms efficacy and safety benefits of Cosentyx® in daily life for psoriasis patients

13/09/2018 - 07:16

Real-world evidence confirms Cosentyx ® efficacy and safety consistent with previously reported clinical studies [1]-[4] Novartis presents a large program of real-world evidence at the 27 th European Academy of [...]

Abeona Therapeutics annonce l'autorisation de commencer l'étude clinique de phase 1/2 sur la thérapie génique pour les patients atteints de MPS IIIB en Espagne

13/09/2018 - 05:51

Un essai clinique pour ABO-101 (AAV-NAGLU) marque le 2e programme MPS III en Europe La société prévoit de créer des sites cliniques supplémentaires dans certains pays européens, dont la France, l'Allemagne et le Royaume [...]

Galapagos raises $300 million gross proceeds in a U.S. public offering

13/09/2018 - 03:16

Mechelen, Belgium, 13 September 2018, 03.00 CET, regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announced today the pricing of its U.S. public offering totaling $ 300 million gross proceeds of 2,575, [...]

Xenon Pharmaceuticals Announces Pricing of $63.0 Million Public Offering of Common Shares

13/09/2018 - 02:15

BURNABY, British Columbia, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage, neurology-focused biopharmaceutical company, today announced the pricing of its underwritten [...]

XBiotech annonce l’arrivée d’un éminent cardiologue de renommée mondiale, le Dr. Peter Libby qui rejoint son Comité scientifique consultatif

13/09/2018 - 02:10

AUSTIN, Texas, 13 sept. 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ : XBIT) a le plaisir d’annoncer la nomination au sein de son Comité scientifique consultatif de Peter Libby, MD. Le Dr. Libby travaillera avec [...]

Resverlogix Announces Voting Results from the 2018 Annual and Special Meeting of Shareholders

13/09/2018 - 00:30

CALGARY, Alberta, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix”, or the "Corporation") (TSX:RVX) today held its Annual and Special Meeting of Shareholders (the “Meeting”) in Calgary, Alberta. A [...]

Zenith Announces Voting Results from the 2018 Annual Meeting of Shareholders

13/09/2018 - 00:00

Archive of the Executive Presentation to be Posted to the Zenith Website CALGARY, Alberta, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Zenith Capital Corp. ("Zenith" or the "Company") announces that, at its annual meeting of [...]

Novartis announces NEJM publication of landmark PARADIGMS study demonstrating significant benefit of Gilenya® in children and adolescents with MS

12/09/2018 - 23:01

Treatment with Gilenya (fingolimod) substantially reduced the debilitating impact of MS, with significant decreases in key measures of disease activity vs. interferon beta-1a MS severely affects the everyday lives of [...]

Galapagos announces launch of proposed public offering

12/09/2018 - 22:54

Mechelen, Belgium, 12 September 2018, 22.45 CET, regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announced today that it intends to offer and sell, subject to market and other conditions, $300 million [...]

Foamix Announces Proposed Follow-on Offering of Ordinary Shares

12/09/2018 - 22:31

REHOVOT, Israel, and BRIDGEWATER, N.J., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (“Foamix”) (Nasdaq: FOMX), a clinical-stage specialty pharmaceutical company focused on developing and [...]

Clearside Biomedical Appoints Viral Kansara as Vice President, Discovery

12/09/2018 - 22:30

ALPHARETTA, Ga., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]

Adamas Announces New Employment Inducement Grant

12/09/2018 - 22:30

EMERYVILLE, Calif., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted six new employees the option [...]

Verrica Announces Successful Phase 2 Innovate Trial and Complete Enrollment of Phase 3 Trials of VP-102 in Molluscum Contagiosum Ahead of Schedule

12/09/2018 - 22:05

Innovate trial results reaffirm Phase 3 protocol design No serious adverse events (SAEs) reported during the Innovate trial Phase 3 pivotal trials for molluscum contagiosum fully enrolled and topline results now [...]

MorphoSys and Galapagos announce U.S. Antitrust Clearance for global license agreement for MOR106 with pharma partner

12/09/2018 - 22:02

Mechelen, Belgium and Planegg/Munich, Germany; 12 September 2018; 22.01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) and MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; NASDAQ: MOR) announced today the [...]

Xenon Pharmaceuticals Announces Proposed Public Offering of Common Shares

12/09/2018 - 22:01

BURNABY, British Columbia, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage, neurology-focused biopharmaceutical company, today announced that it has commenced an [...]

Progenics Pharmaceuticals Reports Top Line Phase 3 Data for Prostate Cancer Imaging Agent 1404

12/09/2018 - 22:01

-Meets Co-Primary Endpoint of Specificity; 1404 Successfully Identifies Patients Without Clinically Significant Prostate Cancer- -Co-Primary Endpoint of Sensitivity to Identify Patients with Clinically Significant [...]

Présentation corporative de Pediapharm

12/09/2018 - 21:52

NE PAS DISTRIBUER AUX SERVICES DE TRANSMISSION DE NOUVELLES DES ÉTATS-UNIS NI DIFFUSER AUX ÉTATS-UNIS. LE NON-RESPECT DE CETTE RESTRICTION PEUT CONSTITUER UNE VIOLATION DE LA LÉGISLATION EN VALEURS MOBILIÈRES DES ÉTATS- [...]

Pediapharm Files Corporate Presentation

12/09/2018 - 21:17

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. MONTREAL, Sept. 12, [...]

Intermountain Healthcare Now Delivers the Nation’s First “One Stick” Hospitalization for Inpatient Blood Draws

12/09/2018 - 18:06

Intermountain, investing in human-centered quality improvements, sets the new clinical standard for safer, more efficient, and more humane blood collection Salt Lake City, UTAH, Sept. 12, 2018 (GLOBE NEWSWIRE) -- As [...]